11 completed, 5 terminated, 2 recruiting, 1 withdrawn. 19 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 19 | Completed 11, Terminated 5, Recruiting 2, Withdrawn 1 |
| Phase 2 | 3 | Completed 1, Recruiting 1, Terminated 1 |
Follow Spinal Cord Neoplasms: new trials by email Literature Review of Spinal Cord Neoplasms trials Research Report on Spinal Cord Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors NEO100 - Pediatric Tumor of CNS, Pediatric Tumor of Brain | Phase 1 | Recruiting | Neonc Technologies, Inc. | 12 | 2026-09-08 | 2026-09-15 |
| RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors RRx-001, Temozolomide, Irinotecan - Brain Tumor, Recurrent, Brain Tumor, Pediatric | Phase 1 | Terminated | EpicentRx, Inc. | 2 | 2023-01-26 | 2024-10-31 |
| Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma Pembrolizumab, Stereotactic Radiation Therapy, Surgical Resection - Glioblastoma Multiforme | Phase 1 / Phase 2 | Recruiting | Chirag G. Patil | 10 | 2021-12-09 | 2026-09-21 |
| Intra-arterial Chemotherapy for Spinal Metastases Melphalan (intra-arterial infusion) - Spinal Diseases, Spinal Metastases | Phase 1 | Completed | Weill Medical College of Cornell University | 12 | 2012-04-01 | 2020-08-03 |
| Beta-Tricalcium Phosphate Bone Graft in Treating Patients Undergoing Surgery For Metastatic Spine Cancer musculoskeletal complications management/prevention, bone graft, quality-of-life assessment - Adult Spinal Cord Neoplasm, Spinal Bone Metastases | Phase 1 | Terminated | University of Southern California | 1 | 2011-06-01 | 2014-02-06 |
| PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors VEGF inhibitor PTC299 - Brain and Central Nervous System Tumors | Phase 1 | Completed | Pediatric Brain Tumor Consortium | 28 | 2010-11-01 | 2015-05-04 |
| Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia gamma-secretase/Notch signalling pathway inhibitor RO4929097, diagnostic laboratory biomarker analysis, pharmacological study - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Choriocarcinoma | Phase 1 | Terminated | National Cancer Institute (NCI) | 129 | 2010-03-01 | 2014-11-05 |
| Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors vorinostat, temozolomide, diagnostic laboratory biomarker analysis - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Choriocarcinoma | Phase 1 | Completed | National Cancer Institute (NCI) | 27 | 2010-02-01 | 2013-05-03 |
| ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors veliparib, temozolomide, pharmacological study - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Germ Cell Tumor | Phase 1 | Completed | National Cancer Institute (NCI) | 31 | 2009-07-01 | 2014-07-09 |
| Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors carboplatin, dasatinib, etoposide phosphate - Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor | Phase 1 / Phase 2 | Terminated | City of Hope Medical Center | 7 | 2008-09-10 | 2026-11-04 |
| MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer MK-0752 - Brain and Central Nervous System Tumors | Phase 1 | Terminated | Pediatric Brain Tumor Consortium | 33 | 2008-07-01 | 2012-03-06 |
| Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment talotrexin, chemotherapy - Brain and Central Nervous System Tumors, Leukemia | Phase 1 | Withdrawn | Children's Oncology Group | 2007-02-01 | 2014-08-08 | |
| Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma ispinesib, laboratory biomarker analysis, pharmacological study - Childhood Burkitt Lymphoma, Childhood Central Nervous System Germ Cell Tumor | Phase 1 | Completed | National Cancer Institute (NCI) | 30 | 2006-06-01 | 2013-01-16 |
| AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors Cediranib Maleate - Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Germ Cell Tumor | Phase 1 | Completed | National Cancer Institute (NCI) | 55 | 2006-03-01 | 2016-03-07 |
| Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors valproic acid - Brain and Central Nervous System Tumors, Unspecified Childhood Solid Tumor, Protocol Specific | Phase 1 | Completed | Children's Oncology Group | 26 | 2005-05-01 | 2014-08-07 |
| Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma Erlotinib hydrochloride - Brain and Central Nervous System Tumors | Phase 1 / Phase 2 | Completed | St. Jude Children's Research Hospital | 62 | 2005-03-01 | 2015-12-04 |
| FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia romidepsin - Blastic Phase Chronic Myelogenous Leukemia, Childhood Central Nervous System Germ Cell Tumor | Phase 1 | Completed | National Cancer Institute (NCI) | 30 | 2002-09-01 | 2013-01-16 |
| SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors lonafarnib - Brain and Central Nervous System Tumors | Phase 1 | Completed | Pediatric Brain Tumor Consortium | 53 | 2002-01-01 | 2009-10-14 |
| Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors filgrastim, carboplatin, cisplatin - Brain Tumors, Central Nervous System Tumors | Phase 1 | Completed | Children's Oncology Group | 94 | 1998-03-01 | 2014-03-28 |
Astrocytoma (14) · Familial ependymoma (12) · Medulloblastoma (12) · Optic Nerve Glioma (12) · Central Nervous System Neoplasms (11) · Choroid Plexus Neoplasms (10) · Oligodendroglioma (9) · Rhabdoid Tumor (8) · Burkitt Lymphoma (4) · Dendritic Cell Sarcoma, Interdigitating (4) · Brain Neoplasms (3) · Glioma (3) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (3) · Recurrence (3)
Central Nervous System Diseases (19) · Neoplasms by Site (19) · Nervous System Diseases (19) · Nervous System Neoplasms (19) · Spinal Cord Diseases (19) · Neoplasms (18) · Neoplasms by Histologic Type (16) · Neoplasms, Germ Cell and Embryonal (16) · Neoplasms, Glandular and Epithelial (16) · Neoplasms, Nerve Tissue (16) · Neoplasms, Neuroepithelial (16) · Neuroectodermal Tumors (16) · Brain Diseases (13) · Glioma (13) · Neuroectodermal Tumors, Primitive (13)
Temozolomide (3) · Carboplatin (2) · etoposide phosphate (2) · 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (1) · 3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid (1) · Blotting, Western (1) · Bone Transplantation (1) · CK0238273 (1) · Calcium Dobesilate (1) · Cisplatin (1) · Cyclophosphamide (1) · Dasatinib (1) · Dexamethasone (1) · Drug Therapy (1) · Erlotinib Hydrochloride (1)
National Cancer Institute (NCI) (6) · Children's Oncology Group (3) · Pediatric Brain Tumor Consortium (3) · Chirag G. Patil (1) · City of Hope Medical Center (1) · EpicentRx, Inc. (1) · Neonc Technologies, Inc. (1) · St. Jude Children's Research Hospital (1) · University of Southern California (1) · Weill Medical College of Cornell University (1)
United States (18) · Canada (4) · Australia (1)
Alberto Broniscer, MD (1) · Athos Patsalides (1) · Bruce H. Cohen, MD (1) · Bryan Oronsky, MD (1) · Chirag G Patil, MD, MS (1) · Heidi V. Russell, MD (1) · Jack M. Su, MD (1) · Jack Su (1) · James Croop, MD, PhD (1) · Josh Neman, PhD (1) · Judith K. Sato, MD (1) · Mark Kieran (1) · Mark W. Kieran, MD, PhD (1) · Maryam Fouladi (1) · Maryam Fouladi, MD (1)
PMID 17634493, PMID 21115653, PMID 23554030
U01CA081457 (4), U01CA097452 (4), P30CA033572 (1), R21CA256421 (1)